10-K | 2020-12-31 | Filed 2021-02-16 |
10-Q | 2020-09-30 | Filed 2020-10-22 |
10-Q | 2020-06-30 | Filed 2020-07-24 |
10-Q | 2020-03-31 | Filed 2020-04-23 |
10-K | 2019-12-31 | Filed 2020-02-18 |
10-Q | 2019-09-30 | Filed 2019-10-23 |
10-Q | 2019-06-30 | Filed 2019-07-24 |
10-Q | 2019-03-31 | Filed 2019-04-23 |
10-K | 2018-12-31 | Filed 2019-02-19 |
10-Q | 2018-09-30 | Filed 2018-10-23 |
10-Q | 2018-06-30 | Filed 2018-07-25 |
10-Q | 2018-03-31 | Filed 2018-04-24 |
10-K | 2017-12-31 | Filed 2018-02-21 |
10-Q | 2017-09-30 | Filed 2017-10-27 |
10-Q | 2017-06-30 | Filed 2017-07-26 |
10-Q | 2017-03-31 | Filed 2017-04-21 |
10-K | 2016-12-31 | Filed 2017-02-23 |
10-Q | 2016-09-30 | Filed 2016-10-31 |
10-Q | 2016-06-30 | Filed 2016-07-28 |
10-Q | 2016-03-31 | Filed 2016-04-29 |
10-K | 2015-12-31 | Filed 2016-02-19 |
10-Q | 2015-09-30 | Filed 2015-11-06 |
10-Q | 2015-06-30 | Filed 2015-08-03 |
10-Q | 2015-03-31 | Filed 2015-05-01 |
10-K | 2014-12-31 | Filed 2015-02-20 |
10-Q | 2014-09-30 | Filed 2014-11-12 |
10-Q | 2014-06-30 | Filed 2014-08-01 |
8-K | 2020-11-30 | |
8-K | 2020-11-02 | |
8-K | 2020-10-21 | |
8-K | 2020-07-24 | |
8-K | 2020-04-22 | |
8-K | 2020-01-24 | |
8-K | 2019-12-04 | |
8-K | 2019-11-12 | |
8-K | 2019-11-01 | |
8-K | 2019-10-22 | |
8-K | 2019-09-29 | |
8-K | 2019-09-23 | |
8-K | 2019-09-19 | |
8-K | 2019-07-24 | |
8-K | 2019-06-27 | |
8-K | 2019-06-24 | |
8-K | 2019-06-10 | |
8-K | 2019-05-03 | |
8-K | 2019-04-23 | |
8-K | 2019-03-04 | |
8-K | 2019-02-19 | |
8-K | 2019-01-25 | |
8-K | 2019-01-25 | |
8-K | 2018-12-20 | |
8-K | 2018-10-23 | |
8-K | 2018-08-31 | |
8-K | 2018-07-26 | |
8-K | 2018-07-25 | |
8-K | 2018-06-29 | |
8-K | 2018-04-24 | |
8-K | 2018-03-30 | |
8-K | 2018-03-21 | |
8-K | 2018-01-26 |
Comps ($MM TTM) | Market Cap | Gross Margin | EV/EBITDA | Ret on Assets | Assets | Liabilities | Revenue | G Profit | Net Income | EBITDA | EV |
---|---|---|---|---|---|---|---|---|---|---|---|
20 20 Global (TWGL) | |||||||||||
024 Pharma (EEIG) | |||||||||||
111 (YI) | 0% | 1,546 | 323 | 0 | 0 | 0 | 0 | -854 | |||
1 800 Flowers Com (FLWS) | 944 | 42% | 13.3 | 6% | 665 | 336 | 1,266 | 534 | 37 | 75 | 1,001 |
10x Genomics (TXG) | 4,805 | 75% | -490.3 | -2% | 573 | 151 | 61 | 46 | -10 | -9 | 4,357 |
12 Retech (RETC) | 0 | 32% | -0.1 | -1,385% | 1 | 20 | 1 | 0 | -15 | -15 | 1 |
11 Good Energy (ELVN) | |||||||||||
1347 Property Insurance Holdings (PIH) | 34 | 0% | 0.4 | -5% | 164 | 108 | 18 | 0 | -8 | -8 | -3 |
1347 Capital Corp (TFSC) | |||||||||||
180 Degree Capital (TURN) | |||||||||||
1847 Holdings (EFSH) | 25% | -2.4 | -15% | 19 | 23 | 27 | 7 | -3 | -1 | 3 | |
1895 Bancorp of Wisconsin (BCOW) | 46,153 | 12,508.1 | -0% | 441 | 383 | 0 | 0 | -0 | 4 | 46,142 | |
1st Constitution Bancorp (FCCY) | 165 | 0% | 4.4 | 1% | 1,343 | 1,204 | 0 | 0 | 14 | 33 | 144 |
1st Franklin Financial (FFC) | 4 | -0.6 | 7% | 905 | 645 | 0 | 0 | 62 | 80 | -46 | |
24 7 Kid Doc (TVMD) | |||||||||||
1st Source (SRCE) | 1,200 | 7.9 | 1% | 6,691 | 5,858 | 0 | 0 | 70 | 136 | 1,073 | |
2050 Motors (ETFM) | 0 | -0.2 | -166,272,400% | 0 | 2 | 0 | 0 | -2 | -2 | 0 | |
21Vianet Group (VNET) | 6,005 | 0% | 11,151 | 5,788 | 0 | 0 | 0 | 0 | 3,344 | ||
22nd Century (XXII) | 302 | 1% | -14.1 | -36% | 62 | 7 | 26 | 0 | -22 | -21 | 302 |
1Life Healthcare (ONEM) |
Balance Sheet ($MM) | 2014-06-30 | 2014-09-30 | 2014-12-31 | 2015-03-31 | 2015-06-30 | 2015-09-30 | 2015-12-31 | 2016-03-31 | 2016-06-30 | 2016-09-30 | 2016-12-31 | 2017-03-31 | 2017-06-30 | 2017-09-30 | 2017-12-31 | 2018-03-31 | 2018-06-30 | 2018-09-30 | 2018-12-31 | 2019-03-31 | 2019-06-30 | 2019-09-30 |
Cash | 107 | 118 | 97 | 52 | 100 | 696 | 161 | 133 | 244 | 133 | 147 | 82 | 128 | 135 | 198 | 196 | 688 | 110 | 166 | 144 | 178 | 210 |
Accounts Receivable | 63 | 60 | 25 | 33 | 51 | 48 | 72 | 92 | 92 | 91 | 80 | 89 | 97 | 83 | 85 | 72 | 86 | 73 | 80 | 71 | 101 | 102 |
Inventory | 6 | 6 | 8 | 13 | ||||||||||||||||||
PP&E | 2,088 | 2,209 | 2,333 | 2,495 | 3,199 | 3,145 | 4,679 | 4,707 | 4,677 | 5,098 | 5,738 | 5,029 | 5,393 | 5,393 | 7,128 | 5,239 | 5,174 | 5,132 | 7,736 | 6,713 | 7,071 | 6,982 |
Assets | 2,876 | 2,775 | 2,727 | 2,928 | 3,719 | 4,217 | 6,092 | 6,700 | 6,736 | 7,369 | 7,150 | 7,092 | 7,479 | 7,782 | 8,395 | 8,286 | 7,794 | 7,850 | 9,405 | 9,293 | 11,768 | 11,595 |
Accounts Payable | ||||||||||||||||||||||
Long-Term Debt | 2,235 | 1,857 | 1,836 | 1,880 | 1,958 | 1,910 | 3,435 | 3,533 | 3,579 | 3,664 | 3,586 | 3,768 | 4,015 | 4,335 | 4,317 | 3,580 | 3,572 | 3,555 | 3,435 | 3,413 | 4,275 | 4,098 |
Liabilities | 2,398 | 2,029 | 2,016 | 2,316 | 2,915 | 2,536 | 4,530 | 4,921 | 4,966 | 5,200 | 4,981 | 4,935 | 5,374 | 5,706 | 6,187 | 4,721 | 3,905 | 3,818 | 3,867 | 3,948 | 5,268 | 5,419 |
Stockholders' Equity | 478 | |||||||||||||||||||||
Income Statement ($MM) | 2014-06-30 | 2014-09-30 | 2014-12-31 | 2015-03-31 | 2015-06-30 | 2015-09-30 | 2015-12-31 | 2016-03-31 | 2016-06-30 | 2016-09-30 | 2016-12-31 | 2017-03-31 | 2017-06-30 | 2017-09-30 | 2017-12-31 | 2018-03-31 | 2018-06-30 | 2018-09-30 | 2018-12-31 | 2019-03-31 | 2019-06-30 | 2019-09-30 |
Revenue | 87 | 89 | 66 | 74 | 107 | 103 | 141 | 165 | 171 | 186 | 176 | 175 | 204 | 177 | 197 | 212 | 225 | 178 | 155 | 177 | 219 | 253 |
Cost of Revenue | ||||||||||||||||||||||
Gross Profit | ||||||||||||||||||||||
R&D | ||||||||||||||||||||||
SG&A | ||||||||||||||||||||||
Tax | 5 | 2 | 3 | 1 | 5 | 3 | 10 | -3 | -9 | 25 | 41 | 8 | 9 | 13 | 135 | 19 | -21 | 15 | -7 | -10 | -18 | |
Net Income | 22 | 24 | 1 | 9 | 23 | 14 | 24 | 5 | 28 | 127 | 185 | 42 | 50 | 38 | -56 | 73 | 296 | 110 | -22 | -22 | -28 | -72 |
Cash Flow ($MM) | 2014-06-30 | 2014-09-30 | 2014-12-31 | 2015-03-31 | 2015-06-30 | 2015-09-30 | 2015-12-31 | 2016-03-31 | 2016-06-30 | 2016-09-30 | 2016-12-31 | 2017-03-31 | 2017-06-30 | 2017-09-30 | 2017-12-31 | 2018-03-31 | 2018-06-30 | 2018-09-30 | 2018-12-31 | 2019-03-31 | 2019-06-30 | 2019-09-30 |
Cash Operating | 37 | 50 | 15 | 66 | 36 | 123 | 49 | 96 | 102 | 81 | 35 | 119 | 83 | 176 | 53 | 130 | 19 | 111 | 122 | |||
Cash Investing | -112 | -52 | -119 | -438 | 4 | -1,236 | -389 | 16 | -847 | 64 | -40 | -228 | -301 | -799 | -6 | 466 | 21 | -1,722 | 182 | |||
Cash Financing | 88 | -19 | 59 | 412 | 560 | 580 | 308 | -2 | 634 | -133 | -61 | 154 | 226 | 640 | -48 | -103 | -62 | 1,645 | -272 |